We are live on
!
Find out more
HCM
Highline Capital Management Portfolio holdings
AUM
$53.5M
1-Year Est. Return
21.72%
This Fund
S&P 500
This Quarter
Est. Return
-6.33%
1 Year Est. Return
-21.72%
3 Year Est. Return
+197.64%
5 Year Est. Return
+251.63%
10 Year Est. Return
–
AUM
$685M
AUM Growth
-$681M
(-50%)
Cap. Flow
-$617M
Cap. Flow
% of AUM
-90.09%
Top 10 Holdings %
Top 10 Hldgs %
69.33%
Holding
41
New
9
Increased
–
Reduced
15
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$61.5M |
| 2 |
Salesforce
CRM
|
+$52.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$51.6M |
| 4 |
Progressive
PGR
|
+$38.2M |
| 5 |
Advanced Micro Devices
AMD
|
+$27.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$69.4M |
| 2 |
Royal Caribbean
RCL
|
+$67.5M |
| 3 |
Take-Two Interactive
TTWO
|
+$64.4M |
| 4 |
ArcelorMittal
MT
|
+$56.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.77% |
| 2 | Healthcare | 19.19% |
| 3 | Technology | 16.49% |
| 4 | Consumer Staples | 13.81% |
| 5 | Communication Services | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PUT
Apple
AAPL
$4.54T
| – | – |
-985,200
| Closed | -$48.7M |
|
27
Adaptive Biotechnologies
ADPT
$3.59B
| – | – |
-121,000
| Closed | -$5.84M |
|
28
Align Technology
ALGN
$12.1B
| – | – |
-100,500
| Closed | -$27.5M |
|
29
BioMarin Pharmaceuticals
BMRN
$11.6B
| – | – |
-607,021
| Closed | -$52M |
|
|
30
Elevance Health
ELV
$81.5B
| – | – |
-246,000
| Closed | -$69.4M |
|
|
FOLD
31
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-1,511,000
| Closed | -$18.9M |
|
32
Marvell Technology
MRVL
$168B
| – | – |
-2,083,400
| Closed | -$49.7M |
|
|
33
ArcelorMittal
MT
$52.9B
| – | – |
-3,112,400
| Closed | -$56.1M |
|
34
Pegasystems
PEGA
$5.02B
| – | – |
-1,006,576
| Closed | -$35.8M |
|
|
35
Royal Caribbean
RCL
$85.1B
| – | – |
-557,250
| Closed | -$67.5M |
|
36
Sysco
SYY
$40.8B
| – | – |
-618,500
| Closed | -$43.7M |
|
|
37
Take-Two Interactive
TTWO
$45.4B
| – | – |
-567,100
| Closed | -$64.4M |
|
38
VICI Properties
VICI
$29B
| – | – |
-2,098,660
| Closed | -$46.3M |
|
39
Voyager Therapeutics
VYGR
$183M
| – | – |
-296,773
| Closed | -$8.08M |
|
|
SAFM
40
CALL
DELISTED
Sanderson Farms Inc
SAFM
| – | – |
-200,000
| Closed | -$27.3M |
|
|
GLUU
41
DELISTED
Glu Mobile Inc.
GLUU
| – | – |
-3,102,500
| Closed | -$22.3M |
|
Similar funds
NHSP
DTIM
BI
MCAI
PCM
FC
AEPIP
SAM
Highline Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Highline Capital Management held 41 positions worth $685M, down 50% from $1.37B the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Highline Capital Management withdrew a net $617M in Q3 2019, closing 16 positions and reducing 15 holdings. Its most notable exit was Elevance Health, an estimated $69.4M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, up from 22% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Highline Capital Management opened a new position in Alibaba worth $59.8M.
- Highline Capital Management's largest Q3 2019 buy was Alibaba: 357,818 shares worth $59.8M.
- Highline Capital Management's biggest Q3 2019 reduction was CATALENT, INC., cutting an estimated $53.8M.
- Highline Capital Management fully exited Elevance Health in Q3 2019, selling an estimated $69.4M.
- Highline Capital Management's ten largest holdings make up 69% of its $685M portfolio in Q3 2019.
- Highline Capital Management opened 9 new positions and closed 16 in Q3 2019.
- Highline Capital Management's portfolio value fell 50% quarter-over-quarter to $685M.
Based on Highline Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.